single molecule array technology simoa neurology 4 plex e (Quanterix)
97
Structured Review
Quanterix
single molecule array technology simoa neurology 4 plex e
Single Molecule Array Technology Simoa Neurology 4 Plex E, supplied by Quanterix, used in various techniques. Bioz Stars score: 97/100, based on 142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecule+array+simoa+technology/N4PE+Advantage+PLUS+Kit/pmc13344891-124-4-14
Average 97 stars, based on 142 article reviews
Single Molecule Array Technology Simoa Neurology 4 Plex E, supplied by Quanterix, used in various techniques. Bioz Stars score: 97/100, based on 142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecule+array+simoa+technology/N4PE+Advantage+PLUS+Kit/pmc13344891-124-4-14
Average 97 stars, based on 142 article reviews
single molecule array technology simoa neurology 4 plex e - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
other:Article Title: Quantification of serum TDP-43 and neurofilament light chain in patients with amyotrophic lateral sclerosis stratified by UNC13A genotype. Article Snippet: Measurement of TDP-43 and NFL in serum samples was performed by single molecule array (Simoa) technology on the Article Title: Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson's disease patients treated with subthalamic stimulation. Article Snippet: All measurements were assessed via single-molecule array (Simoa) technology with an Concentration Assay:Article Title: Motor phenotypes and neurofilament light chain in genetic amyotrophic lateral sclerosis-results from a multicenter screening program. Article Snippet: .. Measurement of sNfL concentration was performed with the single Article Title: Motor phenotypes and neurofilament light chain in genetic amyotrophic lateral sclerosis—results from a multicenter screening program Article Snippet: .. Measurement of sNfL concentration was performed with the single Clinical Proteomics:Article Title: Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease. Article Snippet: Introduction Progression in Alzheimer’s disease (AD) involves three main interrelated biological axes—tau deposition, neurodegeneration, and neuroinflammation—that jointly drive cognitive decline.. Although several cerebrospinal fluid (CSF) and plasma biomarkers along these axes are well validated for diagnosis, their value for prognosis remains uncertain.. We assessed how baseline markers of each axis predict cognitive trajectories in biomarker-confirmed AD. Article Title: Diagnostic and Prognostic Utility of Plasma p‐tau217 for Alzheimer's Disease in Chinese Elderly: Insights From the SILCODE Study With a Derived Threshold Article Snippet: .. Plasma p‐tau217 concentrations were determined via single‐molecule array (Simoa) technology on the Article Title: Interleukin-6 is Associated with White Matter Hyperintensities and Cognition Independent of Alzheimer’s Disease Plasma Biomarkers – HABS-HD Article Snippet: 22 Assay preparation was performed using a custom automated StarPlus liquid-handling system (Hamilton Robotics, Reno, NV). .. Plasma concentrations of biomarkers were measured with single molecule array (Simoa) technology on the Article Title: Plasma interferon-alpha protein levels during pregnancy are associated with lower birth weight in systemic lupus erythematosus Article Snippet: .. IFN-α protein concentration was measured in plasma samples diluted 1:1 in Protein Concentration:Article Title: Plasma interferon-alpha protein levels during pregnancy are associated with lower birth weight in systemic lupus erythematosus Article Snippet: .. IFN-α protein concentration was measured in plasma samples diluted 1:1 in |